4875.TUS58468P2065
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 for the Treatment of Progressive MS
16 days ago | San Diego Biotechnology
LA JOLLA, Calif., Dec. 29, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
MediciNova Announces Positive Optical Coherence Tomography Results from the SPRINT-MS Phase 2b Trial of MN-166 in Progressive MS Published in Multiple Sclerosis Journal
1 month ago | San Diego Biotechnology
LA JOLLA, Calif., Nov. 25, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
MediciNova Announces Positive Clinical Results Regarding MN-166 for Prevention of Chemotherapy-induced Peripheral Neuropathy Published in Cancer Chemotherapy and Pharmacology
3 monthes ago | San Diego Biotechnology
LA JOLLA, Calif., Sept. 24, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
MediciNova Announces that BioComo's Intranasal RS Virus Vaccine Successfully Induced Neutralizing Antibodies against the RS Virus in Mice using BC-PIV Technology
4 monthes ago | San Diego Biotechnology
LA JOLLA, Calif., Sept. 11, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
MediciNova Announces Positive Preclinical Results Regarding MN-166 in Glioblastoma Published in Frontiers in Immunology
6 monthes ago | San Diego Biotechnology
LA JOLLA, Calif., June 25, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Europe
6 monthes ago | San Diego Biotechnology | 2 articles
LA JOLLA, Calif., June 23, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 for the Treatment of Glioblastoma
8 monthes ago | San Diego Biotechnology
LA JOLLA, Calif., April 20, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Advanced NASH in Japan
10 monthes ago | San Diego Biotechnology
LA JOLLA, Calif., Feb. 17, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
MediciNova Receives Notice of Intention to Grant for New Patent Covering MN-001 for the Treatment of Idiopathic Pulmonary Fibrosis in Europe
11 monthes ago | San Diego Biotechnology
LA JOLLA, Calif., Jan. 27, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Idiopathic Pulmonary Fibrosis in Japan
One year ago | San Diego Biotechnology
LA JOLLA, Calif., Oct. 07, 2019 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...
Register you to post on BioTech Mag
Free Registration
World Biotechnology Congress 2019
Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...
World Biotechnology Congress 2019
Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...
2nd International Conference on Tissue Science and Regenerative Medicine
This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...
FT: Vaccine makers race to fix vaccine supply issues
GreenLight Biosciences explain to the Financial Times the vaccine supply issues for a Covid-19 vaccine. GreenLight Biosciences spoke to the Financial Times about the vaccine... Read more ...
Primer on Carbon Dioxide Removal Provides Vital Resource at Critical Time
Berkeley Lab researchers are working on ways to sequester more carbon in soil, including through agricultural practices. Scientists say that any serious plan to address... Read more ...
A 1-Atom-Deep Look at a Water-Splitting Catalyst
This illustration shows two possible types of surface layers for a catalyst that performs the water-splitting reaction, the first step in making hydrogen fuel: The gray surface... Read more ...
New Research Technique Sheds Light on Least Understood Part of Lithium Batteries
A scientist works on the MALDI (matrix-assisted laser desorption/ionization) mass spectrometer at Berkeley Lab's Molecular Foundry. One of the aspects of lithium-ion batteries... Read more ...
Ozone Generators May Help Remediate Contamination Caused by Thirdhand Smoke
Residue from cigarettes can linger on indoor surfaces for years and even decades. In 10 years of studying thirdhand smoke, which is the toxic cigarette residue that clings to... Read more ...
Financial Times: Get vaccine new variant ready
GreenLight Biosciences explain to the Financial Times how messenger RNA can help get the Covid-19 vaccine new variant ready. GreenLight Biosciences spoke to the Financial Times... Read more ...
Shine On: Avalanching Nanoparticles Break Barriers to Imaging Cells in Real Time
From left: Experimental images of thulium-doped avalanching nanoparticles separated by 300 nanometers; at right, simulations of the same material. (Credit: Berkeley Lab and... Read more ...
How a gene linked to the circadian clock could point to new prostate cancer...
How a gene linked to the circadian clock could point to new prostate cancer treatments arlene.weintraub Fri, 01/15/2021 - 08:15 Read more ...
Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up
Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up ntaylor Fri, 01/15/2021 - 07:49 Read more ...
Ex-Merck scientist accused of stealing trade secrets on Keytruda, raising...
Ex-Merck scientist accused of stealing trade secrets on Keytruda, raising threat of 10-year prison term ntaylor Fri, 01/15/2021 - 05:49 Read more ...